Relationship of iothalamate clearance and NRM in patients receiving fludarabine and melphalan reduced-intensity conditioning

The reduced-intensity conditioning regimen, fludarabine and melphalan, is frequently used in allogeneic hematopoietic stem cell transplantation (HSCT). Melphalan and the active metabolite of fludarabine, F-ara-A, are excreted via the kidneys. Existing methods to assess clearance in this setting are...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutzke, Jade L., Merten, Julianna A., Pawlenty, Amanda G., Barreto, Erin F., Bartoo, Gabe T., Mara, Kristin C., Litzow, Mark R., Hogan, William J., Shah, Mithun V., Mangaonkar, Abhishek A., Leung, Nelson, Alkhateeb, Hassan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Hematopoiesis and Stem Cells
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278281/
https://www.ncbi.nlm.nih.gov/pubmed/35522968
http://dx.doi.org/10.1182/bloodadvances.2021006395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278281/
https://www.ncbi.nlm.nih.gov/pubmed/35522968
http://dx.doi.org/10.1182/bloodadvances.2021006395

Ejemplares similares